NCT04239339View on ClinicalTrials.gov

Serotonergic Modulation of Cognition, Emotion and Brain Activation in Healthy Volunteers

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

April 28, 2020

Primary Completion Date

October 30, 2022

Study Completion Date

October 30, 2022

Conditions
Healthy
Interventions
DRUG

Escitalopram 20 mg

20mg daily for approximately 3 weeks.

DRUG

Placebo

Placebo daily for approximately 3 weeks.

Trial Locations (1)

DK-2100

Neurobiology Research Unit, Copenhagen

All Listed Sponsors
collaborator

University of Cambridge

OTHER

collaborator

Lundbeck Foundation

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT04239339 - Serotonergic Modulation of Cognition, Emotion and Brain Activation in Healthy Volunteers | Biotech Hunter | Biotech Hunter